Inhibition of Breast and Ovarian Tumor Growth through Multiple Signaling Pathways by Using Retrovirus-mediated Small Interfering RNA against Her-2/neu Gene Expression
Authors:
- Kathy Qi CaiKCKathy Qi Cai
- Jennifer A. Thompson-LanzaJTJennifer A. Thompson-Lanza
- Robert C. BastRobert C. Bast
- Jinsong LiuJLJinsong Liu
Open Access
- 1 February 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (6) , 4339-4345
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- RETRACTED: Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesisCancer Cell, 2003
- RNA interference: the new somatic cell genetics?Cancer Cell, 2002
- Effective expression of small interfering RNA in human cellsNature Biotechnology, 2002
- U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cellsNature Biotechnology, 2002
- Molecular mechanisms underlying ErbB2/HER2 action in breast cancerOncogene, 2000
- Initiation of translation from a downstream in-frame AUG codon on BRCA1 can generate the novel isoform protein ΔBRCA1(17aa)Oncogene, 2000
- HER-2/neu Blocks Tumor Necrosis Factor-induced Apoptosis via the Akt/NF-κB PathwayJournal of Biological Chemistry, 2000
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986